Latest Financials News

Equity Story Group reports a strong quarter for its Growth Fund but faces setbacks with the termination of the Baker Young acquisition. The company is now pursuing a significant capital raise and has restructured its board to drive future growth.

Yugo Metals has raised $3.5 million to fund its first-ever diamond drilling program targeting gold anomalies at its Sinjakovo project in Bosnia. The company also advances community and regulatory engagement for its Sockovac license while maintaining a cautious cash position.

Nova Eye Medical reported a robust 32% increase in global sales excluding China for Q1 FY26 and secured regulatory approval for its iTrack™ Advance device in China, setting the stage for expanded market penetration.

Articore Group has initiated an on-market share buy-back of up to 10% of its issued capital, signaling renewed confidence in its turnaround and long-term growth prospects.

Flagship Minerals has secured a valuable historical dataset from Anglo, significantly advancing its Pantanillo Gold Project towards feasibility and construction, supported by a strategic EPC partnership and a recent $4 million capital raise.

QMines Limited has completed the acquisition of the Mt Mackenzie gold-silver project, upgraded its resource base, and advanced drilling at Develin Creek, supported by a $9 million capital raise to fund exploration and development.

Pinnacle Minerals has raised $2.2 million to fund its strategic expansion into the US critical minerals sector, acquiring eight new projects and commencing exploration activities in Idaho and Washington State.

Cluey Ltd reported a stable Q1 FY26 revenue of $7.4 million alongside its strongest-ever underlying EBITDA, as it accelerates investment in AI-driven educational products set to launch in 2026.

Knosys Limited reported robust Q1 FY26 results with $3.5 million in cash receipts and a steady $9.5 million annual recurring revenue, while advancing its AI-driven Libero X product and appointing a new Chair.

Capstone Copper delivered a landmark Q3 2025 with record revenue, lowest-ever cash costs, and a strategic joint venture that derisks its Santo Domingo project. The company’s growth trajectory is bolstered by robust production gains and promising exploration results.

Cluey Ltd has reported its strongest-ever underlying EBITDA alongside improved cash flow, while ramping up investments in AI-powered product development set to launch in 2026.

Resmed Inc. kicked off fiscal 2026 with robust 9% revenue growth and a notable 290 basis points gross margin expansion, signaling strong momentum in home healthcare innovation. The company also declared a $0.60 dividend and executed a $150 million share buyback, underscoring confidence in its strategic direction.